ACI-206

N/A

Report date: 2025/06/11 11:16:37
NME

Base Information

Drug NameACI-206
Drug Alias NameAmyloid-beta Beta-sheet Formation Inhibitors (AC Immune)ACI-260ACI-206
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsMacular DegenerationGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsMacular DegenerationGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A